Startup Funding News

Explore funding rounds, the companies behind them and the investors taking part.

Rounds: 4,776
Disclosed funding: $349.5B
Median round: $14.5M

Funding rounds
Company	Amount	Round	Sector	Country	Investors	Announced
PD Perceptive DiscoveryBiotech · United KingdomCompany profile Provides preclinical and translational solutions for oncology and radiopharmaceutical programs Provides preclinical and translational solutions for oncology and radiopharmaceutical programs	$15M	StrategicUndisclosed	Biotech	United Kingdom	Investors CapVest Partners	Jan 8
PM Parabilis MedicinesBiotech · United StatesCompany profile Develops medicines targeting historically undruggable protein targets in cancer Develops medicines targeting historically undruggable protein targets in cancer	$305M	Series FSeries C+	Biotech	United States	Investors Alderline Group ARCH Venture Partners +21 Catalio Capital Management Cormorant Asset Management Farallon Capital Management Fidelity Management & Research Company Foresite Capital Frazier Life Sciences General Catalyst GV (Google Ventures)HBM Healthcare Invus Janus Henderson Investors Marshall Wace Milky Way Investments Nextech Invest RA Capital Management Rock Springs Capital Samsara BioCapital Sixty Degree Capital Soleus Capital T. Rowe Price Associates venBio Partners	Jan 8
A Articul8AI · United StatesCompany profile Develops specialized AI systems for regulated industries Develops specialized AI systems for regulated industries	$70M	Series B	AI	United States	Investors Adara Ventures Aditya Birla Ventures	Jan 7
U UbyxFintech · United KingdomCompany profile Provides a global clearing system for tokenised deposits and stablecoins Provides a global clearing system for tokenised deposits and stablecoins	Undisclosed	StrategicUndisclosed	Fintech	United Kingdom	Investors Barclays	Jan 7
Nocion TherapeuticsBiotech · United StatesCompany profile Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch.	$23M	Series B+Series B	Biotech	United States	Investors Undisclosed	Jan 7
S STRM.BIOBiotech · United StatesCompany profile Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy	$8M	Seed2Seed	Biotech	United States	Investors Blue Bay Capital Fund Boehringer Ingelheim Ventures +2 Delos Capital Recordati	Jan 7
PT Poplar TherapeuticsHealthtech · United StatesCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions	$50M	Series A	Healthtech	United States	Investors Platanus SR One +1 Vida Ventures	Jan 7
MT Mediar TherapeuticsBiotech · United StatesCompany profile Develops therapies to halt fibrosis in multiple organ systems Develops therapies to halt fibrosis in multiple organ systems	$76M	Series B	Biotech	United States	Investors Alexandria Real Estate Trust (ARE)Amplitude Ventures +3 Asahi Kasei Pharma Ventures ICG Longwood Fund	Jan 7
C CertHubHealthtech · GermanyCompany profile Uses AI-driven automation to accelerate medical device approvals and compliance Uses AI-driven automation to accelerate medical device approvals and compliance	€6.2M	Undisclosed	Healthtech	Germany	Investors Calm/Storm Cusp Capital +2 D11Z UnternehmerTUM	Jan 7
PS Prudentia SciencesBiotech · United StatesCompany profile Provides AI-native due diligence for life sciences dealmaking Provides AI-native due diligence for life sciences dealmaking	$20M	Series A	Biotech	United States	Investors GV (Google Ventures)Iaso Ventures +3 McKesson Ventures SignalFire Virtue	Jan 7